CryoGen will contribute to changing medicine forever. We are in the process of creating the technology for reversible cryopreservation of organs and developing cryobanking for transplantation purposes. Over time, our cryobank will store organs and tissues grown from stem cells or created via 3D bioprinting. Cryopreservation will allow medical specialists more time to use advanced techniques for saving millions of lives.
Cryogen will become the undisputed leader in the cryonics industry in Europe and most likely in Eurasia. Switzerland was chosen as the base of the project’s global headquarters not by chance: euthanasia is allowed there, and, hence, the highest quality cryonics is possible at the moment. Currently, Europe has a very high demand for cryonics, and even now about 25% of the KrioRus contracts are concluded with customers from Western Europe.
Cryogen will strengthen KrioRus’s position in Russia with the opening of a new cryocenter in the vicinity of Moscow as well as with the accelerated development of the most affordable and efficient nanocryonics technology. Russian legislation makes it possible to integrate auxiliary services such as DNA preservation, cryobanking of organs, genetic archives, etc.
Cryogen has a unique opportunity to become the world’s leader in providing space anabiosis services — we can foresee that our technologies soon will be used for long-duration space travel. And the first step in that direction has already been made.
We have opened offices in the United States (New York), Italy (Mirandola), in St. Petersburg, reached an agreement with its partners in Riga (Latvia), London (UK), Kiev (Ukraine), Minsk (Belarus), Volgograd , Samara, Chelyabinsk and Izhevsk